Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 05:55
09/25/20
09/25
05:55
09/25/20
05:55
ABT

Abbott

$100.91 /

-1.81 (-1.76%)

, AMRN

Amarin

$3.64 /

-0.035 (-0.95%)

, AMYT

Amryt Pharma

$11.57 /

-0.48 (-3.98%)

, AZN

AstraZeneca

$54.18 /

-1.495 (-2.69%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$382.64 /

-2.39 (-0.62%)

, GILD

Gilead

$62.26 /

-0.85 (-1.35%)

, LLY

Eli Lilly

$148.89 /

-1 (-0.67%)

, MDT

Medtronic

$101.30 /

-0.52 (-0.51%)

, MRK

Merck

$83.17 /

+0.54 (+0.65%)

, NVO

Novo Nordisk

$68.25 /

-1.195 (-1.72%)

, NVS

Novartis

$86.30 /

-1.15 (-1.32%)

, PODD

Insulet

$216.60 /

-11.07 (-4.86%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$50.75 /

+0.15 (+0.30%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$1.73 /

-0.09 (-4.95%)

56th Virtual Annual…

56th Virtual Annual Meeting of EASD will be held on September 21-25. Webcast Link

ShowHide Related Items >><<
VTVT vTv Therapeutics
$1.73 /

-0.09 (-4.95%)

TNDM TNDM
/

+

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$216.60 /

-11.07 (-4.86%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

AMYT Amryt Pharma
$11.57 /

-0.48 (-3.98%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$3.64 /

-0.035 (-0.95%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$11.57 /

-0.48 (-3.98%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$382.64 /

-2.39 (-0.62%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$62.26 /

-0.85 (-1.35%)

09/24/20 H.C. Wainwright
Durect study designed to support full approval, says H.C. Wainwright
09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
LLY Eli Lilly
$148.89 /

-1 (-0.67%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$101.30 /

-0.52 (-0.51%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$83.17 /

+0.54 (+0.65%)

09/24/20 Roth Capital
Merck data suggests 'another shot on goal' for Jounce, says Roth Capital
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$86.30 /

-1.15 (-1.32%)

09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/23/20 Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
PODD Insulet
$216.60 /

-11.07 (-4.86%)

08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

09/23/20 BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
09/23/20 Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
SNY Sanofi
$50.75 /

+0.15 (+0.30%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$1.73 /

-0.09 (-4.95%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
TNDM TNDM
/

+

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$216.60 /

-11.07 (-4.86%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

  • 13
    May
SNY Sanofi
$50.75 /

+0.15 (+0.30%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

TNDM TNDM
/

+

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

PODD Insulet
$216.60 /

-11.07 (-4.86%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

Thursday
Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 04:55
09/24/20
09/24
04:55
09/24/20
04:55
ABT

Abbott

$102.72 /

-2.07 (-1.98%)

, AMRN

Amarin

$3.68 /

-0.165 (-4.30%)

, AMYT

Amryt Pharma

$12.05 /

+ (+0.00%)

, AZN

AstraZeneca

$55.68 /

+0.235 (+0.42%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$386.13 /

-12 (-3.01%)

, GILD

Gilead

$63.10 /

-0.29 (-0.46%)

, LLY

Eli Lilly

$149.89 /

-0.04 (-0.03%)

, MDT

Medtronic

$102.97 /

-1.36 (-1.30%)

, MRK

Merck

$82.63 /

-0.3 (-0.36%)

, NVO

Novo Nordisk

$69.45 /

+0.36 (+0.52%)

, NVS

Novartis

$87.45 /

-1.42 (-1.60%)

, PODD

Insulet

$227.64 /

-2.48 (-1.08%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$50.60 /

+0.7 (+1.40%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$1.82 /

-0.06 (-3.19%)

56th Virtual Annual…

56th Virtual Annual Meeting of EASD will be held on September 21-25. Webcast Link

ShowHide Related Items >><<
VTVT vTv Therapeutics
$1.82 /

-0.06 (-3.19%)

TNDM TNDM
/

+

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$227.64 /

-2.48 (-1.08%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

NVO Novo Nordisk
$69.45 /

+0.36 (+0.52%)

MRK Merck
$82.63 /

-0.3 (-0.36%)

MDT Medtronic
$102.97 /

-1.36 (-1.30%)

LLY Eli Lilly
$149.89 /

-0.04 (-0.03%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DXCM DexCom
$386.13 /

-12 (-3.01%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.68 /

+0.235 (+0.42%)

AMYT Amryt Pharma
$12.05 /

+ (+0.00%)

AMRN Amarin
$3.68 /

-0.165 (-4.30%)

ABT Abbott
$102.72 /

-2.07 (-1.98%)

ABT Abbott
$102.72 /

-2.07 (-1.98%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$3.68 /

-0.165 (-4.30%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$12.05 /

+ (+0.00%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$55.68 /

+0.235 (+0.42%)

09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$386.13 /

-12 (-3.01%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$63.10 /

-0.29 (-0.46%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
LLY Eli Lilly
$149.89 /

-0.04 (-0.03%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$102.97 /

-1.36 (-1.30%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$82.63 /

-0.3 (-0.36%)

09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
NVO Novo Nordisk
$69.45 /

+0.36 (+0.52%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$87.45 /

-1.42 (-1.60%)

09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/23/20 Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
PODD Insulet
$227.64 /

-2.48 (-1.08%)

08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

09/23/20 BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
09/23/20 Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
SNY Sanofi
$50.60 /

+0.7 (+1.40%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$1.82 /

-0.06 (-3.19%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
TNDM TNDM
/

+

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$227.64 /

-2.48 (-1.08%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

NVO Novo Nordisk
$69.45 /

+0.36 (+0.52%)

MRK Merck
$82.63 /

-0.3 (-0.36%)

MDT Medtronic
$102.97 /

-1.36 (-1.30%)

LLY Eli Lilly
$149.89 /

-0.04 (-0.03%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DXCM DexCom
$386.13 /

-12 (-3.01%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.68 /

+0.235 (+0.42%)

AMRN Amarin
$3.68 /

-0.165 (-4.30%)

ABT Abbott
$102.72 /

-2.07 (-1.98%)

  • 13
    May
SNY Sanofi
$50.60 /

+0.7 (+1.40%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

MRK Merck
$82.63 /

-0.3 (-0.36%)

MDT Medtronic
$102.97 /

-1.36 (-1.30%)

LLY Eli Lilly
$149.89 /

-0.04 (-0.03%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DXCM DexCom
$386.13 /

-12 (-3.01%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.68 /

+0.235 (+0.42%)

AMRN Amarin
$3.68 /

-0.165 (-4.30%)

ABT Abbott
$102.72 /

-2.07 (-1.98%)

TNDM TNDM
/

+

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

PODD Insulet
$227.64 /

-2.48 (-1.08%)

NVS Novartis
$87.45 /

-1.42 (-1.60%)

NVO Novo Nordisk
$69.45 /

+0.36 (+0.52%)

MRK Merck
$82.63 /

-0.3 (-0.36%)

MDT Medtronic
$102.97 /

-1.36 (-1.30%)

LLY Eli Lilly
$149.89 /

-0.04 (-0.03%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

DXCM DexCom
$386.13 /

-12 (-3.01%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.68 /

+0.235 (+0.42%)

AMRN Amarin
$3.68 /

-0.165 (-4.30%)

ABT Abbott
$102.72 /

-2.07 (-1.98%)

SNY Sanofi
$50.60 /

+0.7 (+1.40%)

NVO Novo Nordisk
$69.45 /

+0.36 (+0.52%)

MRK Merck
$82.63 /

-0.3 (-0.36%)

MDT Medtronic
$102.97 /

-1.36 (-1.30%)

LLY Eli Lilly
$149.89 /

-0.04 (-0.03%)

GILD Gilead
$63.10 /

-0.29 (-0.46%)

AZN AstraZeneca
$55.68 /

+0.235 (+0.42%)

AMRN Amarin
$3.68 /

-0.165 (-4.30%)

ABT Abbott
$102.72 /

-2.07 (-1.98%)

Wednesday
Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 05:55
09/23/20
09/23
05:55
09/23/20
05:55
ABT

Abbott

$104.79 /

-1.12 (-1.06%)

, AMRN

Amarin

$3.84 /

-0.16 (-4.00%)

, AMYT

Amryt Pharma

$12.05 /

-0.4 (-3.21%)

, AZN

AstraZeneca

$55.44 /

-0.465 (-0.83%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$398.11 /

+7.06 (+1.81%)

, GILD

Gilead

$63.39 /

-0.84 (-1.31%)

, LLY

Eli Lilly

$149.93 /

-1.3 (-0.86%)

, MDT

Medtronic

$104.33 /

-0.445 (-0.42%)

, MRK

Merck

$82.93 /

-0.18 (-0.22%)

, NVO

Novo Nordisk

$69.09 /

+0.105 (+0.15%)

, NVS

Novartis

$88.87 /

-0.65 (-0.73%)

, PODD

Insulet

$230.56 /

+6.05 (+2.69%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$49.90 /

-0.98 (-1.93%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$1.88 /

-0.19 (-9.18%)

56th Virtual Annual…

56th Virtual Annual Meeting of EASD will be held on September 21-25. Webcast Link

ShowHide Related Items >><<
VTVT vTv Therapeutics
$1.88 /

-0.19 (-9.18%)

TNDM TNDM
/

+

SNY Sanofi
$49.90 /

-0.98 (-1.93%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$230.56 /

+6.05 (+2.69%)

NVS Novartis
$88.87 /

-0.65 (-0.73%)

NVO Novo Nordisk
$69.09 /

+0.105 (+0.15%)

MRK Merck
$82.93 /

-0.18 (-0.22%)

MDT Medtronic
$104.33 /

-0.445 (-0.42%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

GILD Gilead
$63.39 /

-0.84 (-1.31%)

DXCM DexCom
$398.11 /

+7.06 (+1.81%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.44 /

-0.465 (-0.83%)

AMYT Amryt Pharma
$12.05 /

-0.4 (-3.21%)

AMRN Amarin
$3.84 /

-0.16 (-4.00%)

ABT Abbott
$104.79 /

-1.12 (-1.06%)

ABT Abbott
$104.79 /

-1.12 (-1.06%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$3.84 /

-0.16 (-4.00%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$12.05 /

-0.4 (-3.21%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$55.44 /

-0.465 (-0.83%)

09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$398.11 /

+7.06 (+1.81%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$63.39 /

-0.84 (-1.31%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$104.33 /

-0.445 (-0.42%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$82.93 /

-0.18 (-0.22%)

09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
NVO Novo Nordisk
$69.09 /

+0.105 (+0.15%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$88.87 /

-0.65 (-0.73%)

09/23/20 Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
09/01/20 Morgan Stanley
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
PODD Insulet
$230.56 /

+6.05 (+2.69%)

08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

09/23/20 Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
SNY Sanofi
$49.90 /

-0.98 (-1.93%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$1.88 /

-0.19 (-9.18%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
TNDM TNDM
/

+

SNY Sanofi
$49.90 /

-0.98 (-1.93%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$230.56 /

+6.05 (+2.69%)

NVS Novartis
$88.87 /

-0.65 (-0.73%)

NVO Novo Nordisk
$69.09 /

+0.105 (+0.15%)

MRK Merck
$82.93 /

-0.18 (-0.22%)

MDT Medtronic
$104.33 /

-0.445 (-0.42%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

GILD Gilead
$63.39 /

-0.84 (-1.31%)

DXCM DexCom
$398.11 /

+7.06 (+1.81%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.44 /

-0.465 (-0.83%)

AMRN Amarin
$3.84 /

-0.16 (-4.00%)

ABT Abbott
$104.79 /

-1.12 (-1.06%)

  • 13
    May
SNY Sanofi
$49.90 /

-0.98 (-1.93%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$88.87 /

-0.65 (-0.73%)

MRK Merck
$82.93 /

-0.18 (-0.22%)

MDT Medtronic
$104.33 /

-0.445 (-0.42%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

GILD Gilead
$63.39 /

-0.84 (-1.31%)

DXCM DexCom
$398.11 /

+7.06 (+1.81%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.44 /

-0.465 (-0.83%)

AMRN Amarin
$3.84 /

-0.16 (-4.00%)

ABT Abbott
$104.79 /

-1.12 (-1.06%)

TNDM TNDM
/

+

SNY Sanofi
$49.90 /

-0.98 (-1.93%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$230.56 /

+6.05 (+2.69%)

NVS Novartis
$88.87 /

-0.65 (-0.73%)

NVO Novo Nordisk
$69.09 /

+0.105 (+0.15%)

MRK Merck
$82.93 /

-0.18 (-0.22%)

MDT Medtronic
$104.33 /

-0.445 (-0.42%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

GILD Gilead
$63.39 /

-0.84 (-1.31%)

DXCM DexCom
$398.11 /

+7.06 (+1.81%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.44 /

-0.465 (-0.83%)

AMRN Amarin
$3.84 /

-0.16 (-4.00%)

ABT Abbott
$104.79 /

-1.12 (-1.06%)

SNY Sanofi
$49.90 /

-0.98 (-1.93%)

NVO Novo Nordisk
$69.09 /

+0.105 (+0.15%)

MRK Merck
$82.93 /

-0.18 (-0.22%)

MDT Medtronic
$104.33 /

-0.445 (-0.42%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

GILD Gilead
$63.39 /

-0.84 (-1.31%)

AZN AstraZeneca
$55.44 /

-0.465 (-0.83%)

AMRN Amarin
$3.84 /

-0.16 (-4.00%)

ABT Abbott
$104.79 /

-1.12 (-1.06%)

Tuesday
Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 04:55
09/22/20
09/22
04:55
09/22/20
04:55
ABT

Abbott

$105.91 /

-1.04 (-0.97%)

, AMRN

Amarin

$4.00 /

-0.18 (-4.31%)

, AMYT

Amryt Pharma

$12.45 /

-0.41 (-3.19%)

, AZN

AstraZeneca

$55.91 /

-0.56 (-0.99%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$391.05 /

+1.78 (+0.46%)

, GILD

Gilead

$64.22 /

-0.83 (-1.28%)

, LLY

Eli Lilly

$151.23 /

-3 (-1.95%)

, MDT

Medtronic

$104.78 /

-2.825 (-2.63%)

, MRK

Merck

$83.11 /

-2.71 (-3.16%)

, NVO

Novo Nordisk

$68.99 /

-0.485 (-0.70%)

, NVS

Novartis

$89.51 /

-1.42 (-1.56%)

, PODD

Insulet

$224.51 /

-0.62 (-0.28%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$50.86 /

-1.57 (-2.99%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$2.07 /

+ (+0.00%)

56th Virtual Annual…

56th Virtual Annual Meeting of EASD will be held on September 21-25. Webcast Link

ShowHide Related Items >><<
VTVT vTv Therapeutics
$2.07 /

+ (+0.00%)

TNDM TNDM
/

+

SNY Sanofi
$50.86 /

-1.57 (-2.99%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$224.51 /

-0.62 (-0.28%)

NVS Novartis
$89.51 /

-1.42 (-1.56%)

NVO Novo Nordisk
$68.99 /

-0.485 (-0.70%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

MDT Medtronic
$104.78 /

-2.825 (-2.63%)

LLY Eli Lilly
$151.23 /

-3 (-1.95%)

GILD Gilead
$64.22 /

-0.83 (-1.28%)

DXCM DexCom
$391.05 /

+1.78 (+0.46%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.91 /

-0.56 (-0.99%)

AMYT Amryt Pharma
$12.45 /

-0.41 (-3.19%)

AMRN Amarin
$4.00 /

-0.18 (-4.31%)

ABT Abbott
$105.91 /

-1.04 (-0.97%)

ABT Abbott
$105.91 /

-1.04 (-0.97%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$4.00 /

-0.18 (-4.31%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$12.45 /

-0.41 (-3.19%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$55.91 /

-0.56 (-0.99%)

09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$391.05 /

+1.78 (+0.46%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$64.22 /

-0.83 (-1.28%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
LLY Eli Lilly
$151.23 /

-3 (-1.95%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$104.78 /

-2.825 (-2.63%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$83.11 /

-2.71 (-3.16%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
NVO Novo Nordisk
$68.99 /

-0.485 (-0.70%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$89.51 /

-1.42 (-1.56%)

09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
09/01/20 Morgan Stanley
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
PODD Insulet
$224.51 /

-0.62 (-0.28%)

08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
SNY Sanofi
$50.86 /

-1.57 (-2.99%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$2.07 /

+ (+0.00%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
TNDM TNDM
/

+

SNY Sanofi
$50.86 /

-1.57 (-2.99%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$224.51 /

-0.62 (-0.28%)

NVS Novartis
$89.51 /

-1.42 (-1.56%)

NVO Novo Nordisk
$68.99 /

-0.485 (-0.70%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

MDT Medtronic
$104.78 /

-2.825 (-2.63%)

LLY Eli Lilly
$151.23 /

-3 (-1.95%)

GILD Gilead
$64.22 /

-0.83 (-1.28%)

DXCM DexCom
$391.05 /

+1.78 (+0.46%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.91 /

-0.56 (-0.99%)

AMRN Amarin
$4.00 /

-0.18 (-4.31%)

ABT Abbott
$105.91 /

-1.04 (-0.97%)

  • 13
    May
SNY Sanofi
$50.86 /

-1.57 (-2.99%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$89.51 /

-1.42 (-1.56%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

MDT Medtronic
$104.78 /

-2.825 (-2.63%)

LLY Eli Lilly
$151.23 /

-3 (-1.95%)

GILD Gilead
$64.22 /

-0.83 (-1.28%)

DXCM DexCom
$391.05 /

+1.78 (+0.46%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.91 /

-0.56 (-0.99%)

AMRN Amarin
$4.00 /

-0.18 (-4.31%)

ABT Abbott
$105.91 /

-1.04 (-0.97%)

TNDM TNDM
/

+

SNY Sanofi
$50.86 /

-1.57 (-2.99%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$224.51 /

-0.62 (-0.28%)

NVS Novartis
$89.51 /

-1.42 (-1.56%)

NVO Novo Nordisk
$68.99 /

-0.485 (-0.70%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

MDT Medtronic
$104.78 /

-2.825 (-2.63%)

LLY Eli Lilly
$151.23 /

-3 (-1.95%)

GILD Gilead
$64.22 /

-0.83 (-1.28%)

DXCM DexCom
$391.05 /

+1.78 (+0.46%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$55.91 /

-0.56 (-0.99%)

AMRN Amarin
$4.00 /

-0.18 (-4.31%)

ABT Abbott
$105.91 /

-1.04 (-0.97%)

SNY Sanofi
$50.86 /

-1.57 (-2.99%)

NVO Novo Nordisk
$68.99 /

-0.485 (-0.70%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

MDT Medtronic
$104.78 /

-2.825 (-2.63%)

LLY Eli Lilly
$151.23 /

-3 (-1.95%)

GILD Gilead
$64.22 /

-0.83 (-1.28%)

AZN AstraZeneca
$55.91 /

-0.56 (-0.99%)

AMRN Amarin
$4.00 /

-0.18 (-4.31%)

ABT Abbott
$105.91 /

-1.04 (-0.97%)

Over a week ago
Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 08:19
09/21/20
09/21
08:19
09/21/20
08:19
ABT

Abbott

$106.95 /

+0.21 (+0.20%)

, AMRN

Amarin

$4.18 /

+ (+0.00%)

, AMYT

Amryt Pharma

$12.45 /

-0.35 (-2.73%)

, AZN

AstraZeneca

$56.47 /

+0.53 (+0.95%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$389.67 /

+3.695 (+0.96%)

, GILD

Gilead

$65.05 /

+0.03 (+0.05%)

, LLY

Eli Lilly

$154.23 /

+1.74 (+1.14%)

, MDT

Medtronic

$107.61 /

-0.26 (-0.24%)

, MRK

Merck

$85.82 /

+0.17 (+0.20%)

, NVO

Novo Nordisk

$69.49 /

-0.05 (-0.07%)

, NVS

Novartis

$90.92 /

+0.07 (+0.08%)

, PODD

Insulet

$224.82 /

+1.08 (+0.48%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$52.42 /

+0.34 (+0.65%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$2.07 /

+0.04 (+1.97%)

56th Virtual Annual…

56th Virtual Annual Meeting of EASD will be held on September 21-25. Webcast Link

ShowHide Related Items >><<
VTVT vTv Therapeutics
$2.07 /

+0.04 (+1.97%)

TNDM TNDM
/

+

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$224.82 /

+1.08 (+0.48%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

AMYT Amryt Pharma
$12.45 /

-0.35 (-2.73%)

AMRN Amarin
$4.18 /

+ (+0.00%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$4.18 /

+ (+0.00%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$12.45 /

-0.35 (-2.73%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/09/20 SVB Leerink
AstraZeneca COVID vaccine hold may cause ripple, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$389.67 /

+3.695 (+0.96%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$65.05 /

+0.03 (+0.05%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$107.61 /

-0.26 (-0.24%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$85.82 /

+0.17 (+0.20%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$90.92 /

+0.07 (+0.08%)

09/10/20 UBS
Novartis upgraded to Buy from Neutral at UBS
09/01/20 Morgan Stanley
Novartis upgraded to Overweight from Equal Weight at Morgan Stanley
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/18/20 Raymond James
Teva could pay damages nearing $1B in DOJ FCA action, says Raymond James
PODD Insulet
$224.82 /

+1.08 (+0.48%)

08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
SNY Sanofi
$52.42 /

+0.34 (+0.65%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$2.07 /

+0.04 (+1.97%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
TNDM TNDM
/

+

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$224.82 /

+1.08 (+0.48%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

AMRN Amarin
$4.18 /

+ (+0.00%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

  • 13
    May
SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

AMRN Amarin
$4.18 /

+ (+0.00%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

TNDM TNDM
/

+

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PODD Insulet
$224.82 /

+1.08 (+0.48%)

NVS Novartis
$90.92 /

+0.07 (+0.08%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

DXCM DexCom
$389.67 /

+3.695 (+0.96%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

AMRN Amarin
$4.18 /

+ (+0.00%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

SNY Sanofi
$52.42 /

+0.34 (+0.65%)

NVO Novo Nordisk
$69.49 /

-0.05 (-0.07%)

MRK Merck
$85.82 /

+0.17 (+0.20%)

MDT Medtronic
$107.61 /

-0.26 (-0.24%)

LLY Eli Lilly
$154.23 /

+1.74 (+1.14%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

AZN AstraZeneca
$56.47 /

+0.53 (+0.95%)

AMRN Amarin
$4.18 /

+ (+0.00%)

ABT Abbott
$106.95 /

+0.21 (+0.20%)

Conference/Events
Morgan Stanley to hold a virtual conference » 08:08
09/16/20
09/16
08:08
09/16/20
08:08
ZTS

Zoetis

$162.21 /

+1.33 (+0.83%)

, GLPG

Galapagos

$135.37 /

+0.75 (+0.56%)

, DBVT

DBV Technologies

$1.97 /

-0.005 (-0.25%)

, CI

Cigna

$166.00 /

-6 (-3.49%)

, BDX

Becton Dickinson

$226.09 /

-9.99 (-4.23%)

, AVTR

Avantor

$21.76 /

-0.17 (-0.78%)

, ALC

Alcon

$57.07 /

+0.28 (+0.49%)

, TDOC

Teladoc

$194.91 /

+1.315 (+0.68%)

, INCY

Incyte

$91.48 /

-1.73 (-1.86%)

, DGX

Quest Diagnostics

$113.56 /

+0.74 (+0.66%)

, JNJ

Johnson & Johnson

$148.88 /

+0.485 (+0.33%)

, PAHC

Phibro Animal Health

$18.50 /

+0.34 (+1.87%)

, ABBV

AbbVie

$90.90 /

+0.43 (+0.48%)

, TNDM

TNDM

/

+

, ABC

AmerisourceBergen

$94.93 /

+0.34 (+0.36%)

, CRY

CryoLife

$16.70 /

+0.355 (+2.17%)

, CTLT

Catalent

$84.40 /

+0.5 (+0.60%)

, TXG

10x Genomics

$118.60 /

-2.35 (-1.94%)

, FULC

Fulcrum Therapeutics

$7.84 /

-0.31 (-3.80%)

, KRYS

Krystal Biotech

$46.20 /

-0.92 (-1.95%)

, MYL

Mylan

$15.93 /

+0.15 (+0.95%)

, LLY

Eli Lilly

$150.09 /

+1.09 (+0.73%)

, SUPN

Supernus

$21.95 /

+0.2 (+0.92%)

, SRRK

Scholar Rock

$16.96 /

+0.54 (+3.29%)

, BHC

Bausch Health

$16.26 /

+0.36 (+2.26%)

, HZNP

Horizon Therapeutics

$79.00 /

+2.36 (+3.08%)

, DRNA

Dicerna

$18.00 /

-0.29 (-1.59%)

, RYTM

Rhythm Pharmaceuticals

$30.19 /

-0.3 (-0.98%)

18th Annual Global…

18th Annual Global Healthcare Virtual Conference will be held on September 14-18 with webcasted presentations to begin on September 16 at 8 am. Webcast LinkWebcast Link

ShowHide Related Items >><<
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CRY CryoLife
$16.70 /

+0.355 (+2.17%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

08/18/20 Argus
Elanco price target raised to $30 from $26 at Argus
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
08/14/20 Edward Jones
Zoetis upgraded to Buy from Hold at Edward Jones
08/12/20
Fly Intel: Top five analyst downgrades
GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Jefferies
Galapagos downgraded to Hold from Buy at Jefferies
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
08/19/20 Piper Sandler
AbbVie commercial efforts easier after Gilead CRL, says Piper Sandler
DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

08/06/20 Societe Generale
DBV Technologies downgraded to Sell at Societe Generale after FDA CRL
08/06/20 Societe Generale
DBV Technologies downgraded to Sell from Buy at Societe Generale
08/05/20 Morgan Stanley
DBV Technologies price target lowered to $2 from $4 at Morgan Stanley
08/05/20 JMP Securities
JMP halves DBV Technologies target but sees positive risk/reward
CI Cigna
$166.00 /

-6 (-3.49%)

09/11/20 Jefferies
Cigna performance 'seems neglected,' says Jefferies
09/01/20 Cleveland Research
Amazon partnership with Cigna would make sense for both, says Cleveland Research
08/06/20 RBC Capital
Ontrak price target raised to $50 from $35 at RBC Capital
07/01/20 SVB Leerink
Cigna reinstated with a Market Perform at SVB Leerink
BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
08/27/20 Wells Fargo
Abbott not focused on bringing Covid-19 test to home, says Wells Fargo
08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
AVTR Avantor
$21.76 /

-0.17 (-0.78%)

09/14/20 Morgan Stanley
Avantor initiated with an Overweight at Morgan Stanley
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
08/03/20 Truist
Avantor price target raised to $29 from $21 at Truist
07/30/20 JPMorgan
Avantor price target raised to $25 from $18 at JPMorgan
ALC Alcon
$57.07 /

+0.28 (+0.49%)

09/01/20 Berenberg
Alcon price target lowered to CHF 62 from CHF 64 at Berenberg
08/27/20 Societe Generale
Societe Generale downgrades Alcon to Sell, says recovery 'already over-priced'
08/27/20 Societe Generale
Alcon downgraded to Sell from Hold at Societe Generale
08/20/20 Stephens
Alcon's new product launches at or above expectations, says Stephens
TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

09/08/20 Oppenheimer
Teladoc price target raised to $250 from $84 at Oppenheimer
09/04/20 Deutsche Bank
Teladoc price target raised to $239 from $225 at Deutsche Bank
09/02/20
Fly Intel: Top five analyst upgrades
09/02/20 Berenberg
Teladoc upgraded to Buy from Hold at Berenberg
INCY Incyte
$91.48 /

-1.73 (-1.86%)

09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

09/11/20 Baird
Quest Diagnostics sentiment and valuation missing big picture, says Baird
09/01/20 Deutsche Bank
Quest to see minimal financial impact from Florida news, says Deutsche Bank
08/28/20 Mizuho
Quest, LabCorp weakness yesterday should be bought, says Mizuho
07/29/20
Fly Intel: Top five analyst upgrades
JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold on valuation at Gabelli
02/06/20 Gabelli
Phibro Animal Health downgraded to Hold from Buy at Gabelli
ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/20/20 Morgan Stanley
AbbVie price target raised to $108 from $95 at Morgan Stanley
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

08/31/20 Argus
Argus sees 'solid' growth opportunities for AmerisourceBergen
08/10/20 Credit Suisse
AmerisourceBergen price target raised to $118 from $111 at Credit Suisse
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
CRY CryoLife
$16.70 /

+0.355 (+2.17%)

05/01/20 Lake Street
CryoLife price target raised to $27 from $22 at Lake Street
04/03/20 Lake Street
CryoLife price target lowered to $22 from $38 at Lake Street
04/02/20 Lake Street
CryoLife should emerge stronger in coming years, says Lake Street
04/02/20 Needham
CryoLife price target lowered to $29 from $38 at Needham
CTLT Catalent
$84.40 /

+0.5 (+0.60%)

09/04/20 Deutsche Bank
Catalent price target raised to $91 from $62 at Deutsche Bank
09/01/20 Baird
Catalent price target raised to $100 from $90 at Baird
09/01/20 RBC Capital
Catalent price target raised to $98 from $94 at RBC Capital
TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

09/15/20 JPMorgan
10x Genomics price target raised to $140 from $110 at JPMorgan
09/09/20 Morgan Stanley
10x Genomics initiated with an Overweight at Morgan Stanley
08/12/20 JPMorgan
10x Genomics price target raised to $110 from $95 at JPMorgan
07/10/20
Fly Intel: Top five analyst initiations
FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
08/12/20 H.C. Wainwright
Fulcrum Therapeutics price target lowered to $20 from $28 at H.C. Wainwright
KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

08/19/20 Chardan
Chardan sees valuation upside through 2022 for Krystal Biotech
03/12/20 SMBC Nikko
Krystal Biotech initiated with an Outperform at SMBC Nikko
03/10/20 H.C. Wainwright
Krystal Biotech price target raised to $68 from $59 at H.C. Wainwright
09/26/19 Guggenheim
Krystal Biotech has 'room to run' despite doubling year-to-date, says Guggenheim
MYL Mylan
$15.93 /

+0.15 (+0.95%)

08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
06/18/20 Raymond James
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'
06/18/20 Wedbush
Patent ruling 'creates a significant issue' for Biogen, says Wedbush
LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
09/03/20 Morgan Stanley
Morgan Stanley upgrades Eli Lilly on diabetes, Alzheimer's opportunities
09/03/20 Morgan Stanley
Eli Lilly upgraded to Overweight from Equal Weight at Morgan Stanley
SUPN Supernus
$21.95 /

+0.2 (+0.92%)

06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
06/15/20 Jefferies
Supernus resumed with a Hold at Jefferies
04/30/20 Piper Sandler
Supernus price target raised to $25 from $17 at Piper Sandler
11/08/19 Berenberg
Supernus downgraded to Hold from Buy at Berenberg
SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

03/12/20
Fly Intel: Top five analyst initiations
03/11/20 Baird
Scholar Rock initiated with an Outperform at Baird
BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

08/24/20 JPMorgan
Bausch Health shares can double into separation, says JPMorgan
08/24/20 H.C. Wainwright
Bausch Health price target lowered to $50 from $64 at H.C. Wainwright
08/19/20 Piper Sandler
Bausch Health risk/reward profile remains attractive, says Piper Sandler
08/07/20 Barclays
Bausch Health price target raised to $28 from $25 at Barclays
HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

09/09/20 JPMorgan
Horizon Therapeutics initiated with an Overweight at JPMorgan
08/27/20
Fly Intel: Top five analyst initiations
08/27/20 Piper Sandler
Piper survey points to longer-term growth for Horizon's Krystexxa
08/27/20 Citi
Horizon Therapeutics initiated with a Buy at Citi
DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

SRRK Scholar Rock
$16.96 /

+0.54 (+3.29%)

RYTM Rhythm Pharmaceuticals
$30.19 /

-0.3 (-0.98%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

HZNP Horizon Therapeutics
$79.00 /

+2.36 (+3.08%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DRNA Dicerna
$18.00 /

-0.29 (-1.59%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CRY CryoLife
$16.70 /

+0.355 (+2.17%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

  • 11
    Sep
  • 20
    Aug
  • 07
    Aug
  • 11
    Jun
  • 21
    May
  • 19
    May
  • 21
    May
  • 04
    Feb
  • 30
    Jan
  • 08
    Jan
  • 16
    Oct
  • 09
    Oct
ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CI Cigna
$166.00 /

-6 (-3.49%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

ZTS Zoetis
$162.21 /

+1.33 (+0.83%)

TXG 10x Genomics
$118.60 /

-2.35 (-1.94%)

TNDM TNDM
/

+

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

SUPN Supernus
$21.95 /

+0.2 (+0.92%)

PAHC Phibro Animal Health
$18.50 /

+0.34 (+1.87%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

KRYS Krystal Biotech
$46.20 /

-0.92 (-1.95%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

GLPG Galapagos
$135.37 /

+0.75 (+0.56%)

FULC Fulcrum Therapeutics
$7.84 /

-0.31 (-3.80%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

DBVT DBV Technologies
$1.97 /

-0.005 (-0.25%)

CTLT Catalent
$84.40 /

+0.5 (+0.60%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

BDX Becton Dickinson
$226.09 /

-9.99 (-4.23%)

AVTR Avantor
$21.76 /

-0.17 (-0.78%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

TDOC Teladoc
$194.91 /

+1.315 (+0.68%)

MYL Mylan
$15.93 /

+0.15 (+0.95%)

LLY Eli Lilly
$150.09 /

+1.09 (+0.73%)

JNJ Johnson & Johnson
$148.88 /

+0.485 (+0.33%)

INCY Incyte
$91.48 /

-1.73 (-1.86%)

DGX Quest Diagnostics
$113.56 /

+0.74 (+0.66%)

CI Cigna
$166.00 /

-6 (-3.49%)

BHC Bausch Health
$16.26 /

+0.36 (+2.26%)

ALC Alcon
$57.07 /

+0.28 (+0.49%)

ABC AmerisourceBergen
$94.93 /

+0.34 (+0.36%)

ABBV AbbVie
$90.90 /

+0.43 (+0.48%)

Over a month ago
Initiation
Fly Intel: Top five analyst initiationsNewPage » 09:46
08/20/20
08/20
09:46
08/20/20
09:46
FLGT

Fulgent Genetics

$44.05 /

+ (+0.00%)

, VRT

Vertiv Holdings

$15.68 /

+ (+0.00%)

, TNDM

TNDM

/

+

, VIR

Vir Biotechnology

$50.36 /

-0.1 (-0.20%)

, CHKP

Check Point

$128.00 /

+ (+0.00%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Fulgent Genetics (FLGT) initiated with an Outperform at Oppenheimer. 2. Vertiv Holdings (VRT) initiated with a Buy at BofA. 3. Tandem Diabetes (TNDM) initiated with an Overweight at Wells Fargo. 4. Vir Biotechnology (VIR) initiated with a Buy at Needham. 5. Check Point (CHKP) initiated with a Hold at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
VRT Vertiv Holdings
$15.68 /

+ (+0.00%)

VIR Vir Biotechnology
$50.36 /

-0.1 (-0.20%)

TNDM TNDM
/

+

FLGT Fulgent Genetics
$44.05 /

+ (+0.00%)

CHKP Check Point
$128.00 /

+ (+0.00%)

FLGT Fulgent Genetics
$44.05 /

+ (+0.00%)

08/20/20 Oppenheimer
Oppenheimer bullish on Fulgent Genetics, initiates with an Outperform
08/19/20 Oppenheimer
Fulgent Genetics initiated with an Outperform at Oppenheimer
08/17/20 Piper Sandler
Fulgent Genetics price target raised to $73 from $68 at Piper Sandler
08/05/20 Piper Sandler
Fulgent Genetics price target raised to $68 from $31 at Piper Sandler
VRT Vertiv Holdings
$15.68 /

+ (+0.00%)

08/20/20 BofA
Vertiv Holdings initiated with a Buy at BofA
08/20/20 BofA
Vertiv Holdings initiated with a Buy at BofA
05/07/20 Deutsche Bank
Vertiv Holdings price target raised to $17 from $11 at Deutsche Bank
04/09/20 Deutsche Bank
Vertiv Holdings upgraded to Buy from Hold at Deutsche Bank
TNDM TNDM
/

+

08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
VIR Vir Biotechnology
$50.36 /

-0.1 (-0.20%)

08/20/20 Needham
Vir Biotechnology initiated with a Buy at Needham
08/20/20 Needham
Vir Biotechnology initiated with a Buy at Needham
08/12/20 Barclays
Vir Biotechnology price target raised to $61 from $44 at Barclays
05/13/20 Barclays
Vir Biotechnology price target raised to $44 from $41 at Barclays
CHKP Check Point
$128.00 /

+ (+0.00%)

08/20/20 Deutsche Bank
Check Point initiated with a Hold at Deutsche Bank
07/23/20 Wedbush
Check Point price target raised to $140 from $125 at Wedbush
07/23/20 Credit Suisse
Check Point price target raised to $125 from $110 at Credit Suisse
07/23/20 BTIG
Check Point price target raised to $143 from $122 at BTIG
VRT Vertiv Holdings
$15.68 /

+ (+0.00%)

VIR Vir Biotechnology
$50.36 /

-0.1 (-0.20%)

TNDM TNDM
/

+

FLGT Fulgent Genetics
$44.05 /

+ (+0.00%)

CHKP Check Point
$128.00 /

+ (+0.00%)

  • 13
    Aug
  • 08
    Jul
  • 14
    Nov
  • 11
    Oct
VIR Vir Biotechnology
$50.36 /

-0.1 (-0.20%)

CHKP Check Point
$128.00 /

+ (+0.00%)

VIR Vir Biotechnology
$50.36 /

-0.1 (-0.20%)

TNDM TNDM
/

+

FLGT Fulgent Genetics
$44.05 /

+ (+0.00%)

CHKP Check Point
$128.00 /

+ (+0.00%)

VIR Vir Biotechnology
$50.36 /

-0.1 (-0.20%)

Initiation
Tandem Diabetes initiated with an Overweight at Wells Fargo » 06:28
08/20/20
08/20
06:28
08/20/20
06:28
TNDM

TNDM

/

+

Wells Fargo analyst…

Wells Fargo analyst Lawrence Biegelsen initiated coverage of Tandem Diabetes with an Overweight rating and $120 price target. The analyst expects the company's current t:slim X2 insulin pump with Control IQ and the launch of its smaller t:sport pump in 2021 to drive share gains in the "growing" insulin pump market. Tandem currently offers the leading automated insulin delivery system on the market with Control IQ, Biegelsen tells investors in a research note. He expects outside the U.S. expansion, UnitedHealth coverage starting July 1, and a "robust" renewal cycle to drive annual revenue growth of 22% from 2019 to 2024.

ShowHide Related Items >><<
TNDM TNDM
/

+

TNDM TNDM
/

+

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
TNDM TNDM
/

+

TNDM TNDM
/

+

Conference/Events
UBS to hold a virtual conference » 04:55
08/13/20
08/13
04:55
08/13/20
04:55
ADPT

Adaptive Biotechnologies

$38.34 /

+1.56 (+4.24%)

, BX

Blackstone

$52.85 /

+0.38 (+0.72%)

, BDX

Becton Dickinson

$257.24 /

+2.24 (+0.88%)

, GH

Guardant Health

$86.82 /

+5.17 (+6.33%)

, ILMN

Illumina

$344.15 /

+3.03 (+0.89%)

, MASI

Masimo

$211.09 /

+1.56 (+0.74%)

, NVTA

Invitae

$29.76 /

+0.775 (+2.67%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, TNDM

TNDM

/

+

, TWST

Twist Bioscience

$62.31 /

+6.72 (+12.09%)

, TXG

10x Genomics

$97.75 /

+0.97 (+1.00%)

Genomics 2.0 Virtual…

Genomics 2.0 Virtual Conference will be held on August 11-13.Webcast Link

ShowHide Related Items >><<
TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

GH Guardant Health
$86.82 /

+5.17 (+6.33%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
BX Blackstone
$52.85 /

+0.38 (+0.72%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
GH Guardant Health
$86.82 /

+5.17 (+6.33%)

08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
06/11/20 BTIG
Guardant Health initiated with a Buy at BTIG
ILMN Illumina
$344.15 /

+3.03 (+0.89%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 Evercore ISI
Illumina downgraded to Underperform from In Line at Evercore ISI
08/07/20 Piper Sandler
Illumina downgraded to Neutral from Overweight at Piper Sandler
07/07/20 Guggenheim
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim
MASI Masimo
$211.09 /

+1.56 (+0.74%)

04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
03/02/20 Raymond James
Masimo 'well positioned' should COVID-19 expand, says Raymond James
NVTA Invitae
$29.76 /

+0.775 (+2.67%)

08/05/20 SVB Leerink
Invitae price target lowered to $34 from $40 at SVB Leerink
08/05/20 Ladenburg
Invitae price target raised to $37.25 from $31.25 at Ladenburg
07/22/20 Oppenheimer
Invitae price target raised to $37 from $29 at Oppenheimer
07/01/20 Benchmark
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
TNDM TNDM
/

+

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

08/12/20 JPMorgan
10x Genomics price target raised to $110 from $95 at JPMorgan
07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Stifel
10x Genomics initiated with a Buy at Stifel
05/12/20 Cowen
10x Genomics price target raised to $85 from $68 at Cowen
TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

GH Guardant Health
$86.82 /

+5.17 (+6.33%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

  • 16
    Jul
  • 04
    Jun
  • 02
    Jun
  • 21
    May
  • 02
    Apr
  • 20
    Feb
  • 24
    Jan
  • 12
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

TXG 10x Genomics
$97.75 /

+0.97 (+1.00%)

TWST Twist Bioscience
$62.31 /

+6.72 (+12.09%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

MASI Masimo
$211.09 /

+1.56 (+0.74%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

GH Guardant Health
$86.82 /

+5.17 (+6.33%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

BDX Becton Dickinson
$257.24 /

+2.24 (+0.88%)

ADPT Adaptive Biotechnologies
$38.34 /

+1.56 (+4.24%)

NVTA Invitae
$29.76 /

+0.775 (+2.67%)

ILMN Illumina
$344.15 /

+3.03 (+0.89%)

BX Blackstone
$52.85 /

+0.38 (+0.72%)

Conference/Events
UBS to hold a virtual conference » 04:55
08/12/20
08/12
04:55
08/12/20
04:55
ADPT

Adaptive Biotechnologies

$36.78 /

-0.82 (-2.18%)

, BX

Blackstone

$52.47 /

+0.175 (+0.33%)

, BDX

Becton Dickinson

$255.00 /

-1.75 (-0.68%)

, GH

Guardant Health

$81.65 /

-4.3 (-5.00%)

, ILMN

Illumina

$341.12 /

-12.19 (-3.45%)

, MASI

Masimo

$209.53 /

-1.96 (-0.93%)

, NVTA

Invitae

$28.98 /

+0.17 (+0.59%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, TNDM

TNDM

/

+

, TWST

Twist Bioscience

$55.59 /

-4.17 (-6.98%)

, TXG

10x Genomics

$96.78 /

+0.01 (+0.01%)

Genomics 2.0 Virtual…

Genomics 2.0 Virtual Conference will be held on August 11-13.Webcast Link

ShowHide Related Items >><<
TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

GH Guardant Health
$81.65 /

-4.3 (-5.00%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

06/18/20 Guggenheim
Adaptive to benefit from increased MRD testing by oncologists, says Guggenheim
06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Goldman Sachs
Adaptive Biotechnologies initiated with a Buy at Goldman Sachs
05/19/20 Guggenheim
Adaptive Biotechnologies price target raised to $50 from $44 at Guggenheim
BX Blackstone
$52.47 /

+0.175 (+0.33%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

08/07/20 Raymond James
Becton Dickinson price target raised to $285 from $265 at Raymond James
07/09/20
Fly Intel: Top five analyst upgrades
07/09/20 Barclays
Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity'
07/09/20 Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
GH Guardant Health
$81.65 /

-4.3 (-5.00%)

08/10/20 Canaccord
Guardion Health Sciences FDA approval landmark event, says Canaccord
06/12/20
Fly Intel: Top five analyst initiations
06/12/20 BTIG
BTIG starts genomic profiling test 'pioneer' Guardant Health at Buy
06/11/20 BTIG
Guardant Health initiated with a Buy at BTIG
ILMN Illumina
$341.12 /

-12.19 (-3.45%)

08/07/20
Fly Intel: Top five analyst downgrades
08/07/20 Evercore ISI
Illumina downgraded to Underperform from In Line at Evercore ISI
08/07/20 Piper Sandler
Illumina downgraded to Neutral from Overweight at Piper Sandler
07/07/20 Guggenheim
Illumina downgraded to Neutral following 81% rise off lows at Guggenheim
MASI Masimo
$209.53 /

-1.96 (-0.93%)

04/20/20
Fly Intel: Top five analyst downgrades
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
04/20/20 Needham
Masimo downgraded to Hold from Buy at Needham
03/02/20 Raymond James
Masimo 'well positioned' should COVID-19 expand, says Raymond James
NVTA Invitae
$28.98 /

+0.17 (+0.59%)

08/05/20 SVB Leerink
Invitae price target lowered to $34 from $40 at SVB Leerink
08/05/20 Ladenburg
Invitae price target raised to $37.25 from $31.25 at Ladenburg
07/22/20 Oppenheimer
Invitae price target raised to $37 from $29 at Oppenheimer
07/01/20 Benchmark
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
TNDM TNDM
/

+

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Stifel
10x Genomics initiated with a Buy at Stifel
05/12/20 Cowen
10x Genomics price target raised to $85 from $68 at Cowen
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

GH Guardant Health
$81.65 /

-4.3 (-5.00%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

  • 16
    Jul
  • 04
    Jun
  • 02
    Jun
  • 21
    May
  • 02
    Apr
  • 20
    Feb
  • 24
    Jan
  • 12
    Sep
RHHBY Roche
$0.00 /

+ (+0.00%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

TXG 10x Genomics
$96.78 /

+0.01 (+0.01%)

TWST Twist Bioscience
$55.59 /

-4.17 (-6.98%)

TNDM TNDM
/

+

RHHBY Roche
$0.00 /

+ (+0.00%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

MASI Masimo
$209.53 /

-1.96 (-0.93%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

GH Guardant Health
$81.65 /

-4.3 (-5.00%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

BDX Becton Dickinson
$255.00 /

-1.75 (-0.68%)

ADPT Adaptive Biotechnologies
$36.78 /

-0.82 (-2.18%)

NVTA Invitae
$28.98 /

+0.17 (+0.59%)

ILMN Illumina
$341.12 /

-12.19 (-3.45%)

BX Blackstone
$52.47 /

+0.175 (+0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.